Skip to content

Clinical trials

Phase 2/3 Recurrence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 2/3 Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20061
20071
20093
20104
20111
20123
20131
20142
20153
20163
20174
20182
20192
20203
20211
20221
20231
20241
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting8
Active, not recruiting7
Terminated7
Not yet recruiting5
Unknown status5
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Nanfang Hospital, Southern Medical University2
Alexion Pharmaceuticals, Inc.1
Amgen1
BioNTech SE1
Bozyaka Training and Research Hospital1
Cambridge University Hospitals NHS Foundation Trust1
Celgene1
Children's Oncology Group1
Clovis Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence52
Neoplasm Metastasis8
Neoplasms4
Glioblastoma3
Lymphoma, Large B-Cell, Diffuse3
Squamous Cell Carcinoma of Head and Neck3
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Delirium2
Demyelinating Diseases2

Trials

Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.